Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).


NDAQ:MNMD - Post by User

Post by Youhillmanon Feb 02, 2021 2:39pm
425 Views
Post# 32448827

Motley Fool likes MMED Potential....

Motley Fool likes MMED Potential....Came across this, thought I'd share, MF has a good track record....I bought this back in October and keep adding to my position, to date I'm up 27%...

The psychedelics industry is an excellent place to find millionaire-maker stocks

Everyone dreams of finding those one-in-a-million stocks that provide investors with incredible growth. The key to finding these millionaire-maker stocks is by searching for businesses with attractive long-term trends before they become widely known by the rest of the market.

Often some of the best stocks are high-quality businesses that are rapidly disrupting an industry. Other times they are the leading companies of a new industry that’s just starting to gain popularity.

Over the past few years, there have been several opportunities like this for investors. Pot stocks were highly rewarding leading up to legalization. Plus, tech stocks are always an industry with the potential to find these investments.

Today, though, the investments are in newly emerging high-growth industries.

Another great growth industry for long-term investors is the psychedelics industry. Right now, the industry is being compared to the cannabis industry back when it was in its infant stages. Many think psychedelics could have significant pharmaceutical potential making these investments very attractive.

Although psychedelics is being compared to cannabis because of the potential to create so many millionaire-maker stocks, down the line, the opportunities are actually far broader.

The hype in the cannabis sector was always about the potential of legalization. With psychedelics, however, there’s a lot more opportunity with the science. This has many well-known investors like Kevin O’Leary and Peter Thiel getting in on the sector. So it’s no surprise that many think the industry could be full of millionaire-maker stocks.

Plus, in addition to the long-term prospects, the industry offers short-term potential now. Investors continue to jump on the bandwagon bringing more momentum to the sector. And with the psychedelic ETF that just launched last week, you can expect the demand for these shares to continue to increase rapidly.

If the potential for psychedelics is something that piques your interest, there are several opportunities to consider. However, one of the top potential millionaire-maker stocks in the sector is Mind Medicine (Mind Med) Inc.

<< Previous
Bullboard Posts
Next >>